Home > Insider Trading > Filing (0000911916-17-000032)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1348649	Colucid Pharmaceuticals Inc.	CLCD	Pharmaceutical Preparations (2834)	203419541

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1639972	C. Linda Hogan	C/O Colucid Pharmaceuticals, Inc. 222 Third Street Cambridge MA 02142	Head, Bus. Dev. And Strategy	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-01-03	718	$6.75	718	No	4	M	Direct
Common Stock	Disposition	2017-01-03	718	$36.25	0	No	4	S	Direct
Common Stock	Acquisiton	2017-01-04	185	$7.56	185	No	4	M	Direct
Common Stock	Disposition	2017-01-04	185	$36.40	0	No	4	S	Direct
Common Stock	Acquisiton	2017-01-05	1,677	$10.00	1,677	No	4	M	Direct
Common Stock	Disposition	2017-01-05	477	$33.55	1,200	No	4	S	Direct
Common Stock	Disposition	2017-01-05	600	$34.40	600	No	4	S	Direct
Common Stock	Disposition	2017-01-05	600	$35.61	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2017-01-03	718	$0.00	718	$6.75
Common Stock	Stock Option (Right to Buy)	Disposition	2017-01-04	185	$0.00	185	$7.56
Common Stock	Stock Option (Right to Buy)	Disposition	2017-01-05	1,677	$0.00	1,677	$10.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
26,594	2026-03-04	No	4	M	Direct
5,741	2025-08-04	No	4	M	Direct
46,966	2025-05-05	No	4	M	Direct

Footnotes

Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Ms. Hogan on March 24, 2016.
Represents the sale of 477 shares in multiple transactions, ranging in price from $33.40 to $34.00 per share, resulting in a weighted average sale price of $33.5548. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
Represents the sale of 600 shares in multiple transactions, ranging in price from $35.60 to $35.65 per share, resulting in a weighted average sale price of $35.6083. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
Options vest in a series of 48 successive equal monthly installments with the first monthly installment vesting on the grant date and the future installments vesting on the first day of each calendar month.
Options vest as follows: one-third of the shares vested on August 4, 2016; and the remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service.
Options vest as follows: 33% of the shares vested on May 5, 2016; and the remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service.